申请人:Sunshine Lake Pharma Co., Ltd.
公开号:US20140134133A1
公开(公告)日:2014-05-15
The present invention provides heteroaromatic derivatives and pharmaceutical acceptable salts and formulations thereof useful in modulating the protein kinase activity, especially phosphatidylinositol 3-kinases (PI3 kinases) and mTOR, and in modulating inter- and/or intra-cellular signaling activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
本发明提供了杂环芳基衍生物及其药用可接受的盐和制剂,用于调节蛋白激酶活性,特别是磷脂酰肌醇3-激酶(PI3激酶)和mTOR,并调节细胞内和/或细胞间信号活动,如增殖、分化、凋亡、迁移和侵袭。该发明还提供了包括这些化合物的药用可接受组合物以及在治疗哺乳动物,特别是人类的高增殖性疾病中使用这些组合物的方法。